Yahoo Finance

Engrail Therapeutics Initiates ENX-104 Clinical Program for the Treatment of Major Depressive Disorder Characterized by Anhedonia

SAN DIEGO, Sept. 18, 2024 (GLOBE NEWSWIRE) -- Engrail Therapeutics, a precision neuroscience company focused on the development of transformational therapies to improve the lives of patients, today ...

ENX Magazine Recognizes Epson Commercial Printing and Imaging Director Gabriel Bagnasco in its 2026 Difference Makers Program

ENX Magazine has selected Gabriel Bagnasco, director of product management, Commercial Printing and Imaging Division, Epson America, as a 2026 Difference Maker. Nominated by his peers, Bagnasco was ...
Business Wire

Engrail Therapeutics Initiates the ENCALM Phase 2 Clinical Trial of ENX-102 in Patients with Generalized Anxiety Disorder

SAN DIEGO--(BUSINESS WIRE)--Engrail Therapeutics™ (Engrail) (the Company), a precision neuroscience company focused on the acquisition, development, and commercialization of transformational therapies ...
Business Wire

Engrail Therapeutics Announces Positive Results of ENX-101 Phase 1b Clinical Study and Prepares for Initiation of ENACT Phase 2 Trial in Focal Epilepsy

SAN DIEGO--(BUSINESS WIRE)--Engrail Therapeutics™ (Engrail) (the Company), a precision neuroscience company focused on the acquisition, development, and commercialization of transformational therapies ...
Detroit Free Press

Auto-ISAC and ENX Association Align to Collaborate on Strengthening Automotive Supply Chain Cybersecurity

WASHINGTON, DC, UNITED STATES, March 17, 2026 /EINPresswire.com/ — The Automotive Information Sharing and Analysis Center (Auto-ISAC), the automotive industry’s ...